Loading Complete
Kristen A. Marrone

Kristen A. Marrone, MD

Medical Oncology

Accepting New Patients
Johns Hopkins Affiliations:
  • Johns Hopkins School of Medicine Faculty

Languages

  • English

14 Insurances Accepted

View all

Gender

Female

About Kristen A. Marrone

Professional Titles

  • Program Director, Hematology/Medical Oncology Fellowship Program

Primary Academic Title

Associate Professor of Oncology

Background

Dr. Kristen Marrone is a thoracic medical oncology specialist in Baltimore, caring for patients with lung cancer and esophageal cancer. She is the Program Director of the Hematology/Medical Oncology Fellowship Program at the Johns Hopkins School of Medicine.

Dr. Marrone received her undergraduate degree in psychology with a neuroscience concentration from Pennsylvania State University. She earned her M.D. from Drexel University College of Medicine. She completed her residency at Yale-New Haven Hospital and performed a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. Marrone joined the Johns Hopkins faculty in 2017.

Her research interests include clinical trial development and translational studies focusing on optimization of immunotherapy in oncogene driven non-small cell lung cancer. 

Dr. Marrone is a member of the American Association of Cancer Research, the American Society of Clinical Oncology, the International Association for Study of Lung Cancer and the Society for Immunotherapy in Cancer.

Clinical Trial Keywords

Non-Small Cell Lung Cancer (NSCLC); epidermal derived growth factor receptor (EGFR); KRAS

Research Interests

Immunotherapy, Non-small Cell Lung Cancer (NSCLC), Oncogene Mutated NSCLC, Tumor Metabolism

Research Summary

Non-small cell lung cancer (NSCLC); oncogene mutated NSCLC; immunotherapy; tumor metabolism

Selected Publications

  • Balaji A, Zhang J, Wills B, Marrone KA, Elmariah H, Yarchoan M, Zimmerman JW, Hajjir K, Venkatraman D, Armstrong DK, Laheru DA, Mehra R, Ho WJ, Reuss JE, Heng J, Vellanki P, Donehower RC, Holdhoff M, Naidoo J. “Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes.” J Oncol Pract. 2019 Sep;15(9):e825-e834

  • Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. “Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.” J Am Soc Nephrol. 2020 Feb;31(2):435-446

  • Suresh K, Naidoo J, Zhong Q, Xiong Y, Mammen J, de Flores MV, Cappelli L, Balaji A, Palmer T, Forde PM, Anagnostou V, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Lin CT, Feller-Kopman D, Lerner AD, Lee H, Shafiq M, Yarmus L, Lipson EJ, Soloski M, Brahmer JR, Danoff SK, D'Alessio F. “The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.” J Clin Invest. 2019 Jul 16;130:4305-4315. Parikh AB, Marrone KA, Becker DJ, Brahmer JR, Ettinger DS, Levy BP. “A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer.” Cancer Treat Res Commun. 2019 May 10;20: 100150

  • Topper MJ, Vaz M, Marrone KA, Brahmer JR, Baylin SB. “The emerging role of epigenetic therapeutics in immuno-oncology.” Nat Rev Clin Oncol. 2020 Feb;17(2):75-90

  • Zhang J, Ji Z, Caushi JX, El Asmar M, Anagnostou V, Cottrell TR, Chan HY, Suri P, Guo H, Merghoub T, Chaft JE, Reuss JE, Tam AJ, Blosser RL, Abu-Akeel M, Sidhom JW, Zhao N, Ha JS, Jones DR, Marrone KA, Naidoo J, Gabrielson E, Taube JM, Velculescu VE, Brahmer JR, Housseau F, Hellmann MD, Forde PM, Pardoll DM, Ji H, Smith KN. “Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer.” Clin Cancer Res. 2019 Nov 21

Courses & Syllabi

  • Mock Tumor Board, 1/1/18
  • Epidemiology, Staging and Molecular Diagnosis in Cancer, 1/1/18
  • Genes to Society Pulmonary Course, Student Presentations, 1/1/17
  • Summer Lecture Series-Lung Cancer Case Review, 1/1/17
  • Oncologic Emergencies, 1/1/16
  • Genes to Society Oncology Course, 1/1/16

Honors

  • Gold Humanism Honor Society, 1/1/13
  • Alpha Omega Alpha, Member, 1/1/11

Graduate Program Affiliations

Memberships

  • American Association of Cancer Research
  • American Society of Clinical Oncology (ASCO)
  • International Association for the Study of Lung Cancer (IASLC)
  • Society for Immunotherapy in Cancer

Locations

  1. Johns Hopkins Bayview Medical Center
    • 300 Mason Lord Drive, Kimmel Cancer Center, Baltimore, MD 21224

    Expertise

    Education

    Johns Hopkins University School of Medicine

    Fellowship, Hematology and Oncology, 2017

    Yale New Haven Health

    Residency, Internal Medicine, 2014

    Drexel University College of Medicine

    Medical Education, MD, 2011

    Board Certifications

    Medical Oncology

    American Board of Internal Medicine, 2017

    Internal Medicine

    American Board of Internal Medicine, 2014

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)

    Ratings & Reviews

    5 out of 5

    37 ratings, 14 reviews

    The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

    Overall Rating by Patient
    Average provider Overall Rating by Patient rating 5 out of 5 stars
    Provider Listened Carefully
    Average provider Provider Listened Carefully rating 4.9 out of 5 stars
    Provider Explained Things Clearly
    Average provider Provider Explained Things Clearly rating 5 out of 5 stars
    Provider Knew Medical History
    Average provider Provider Knew Medical History rating 4.9 out of 5 stars
    Provider Showed Respect
    Average provider Provider Showed Respect rating 5 out of 5 stars
    Provider Spent Enough Time
    Average provider Provider Spent Enough Time rating 5 out of 5 stars
    Search reviews
      5 out of 5 stars
      Reviewed on 12/10/2024

      They r the best makes u feel cared for

      5 out of 5 stars
      Reviewed on 11/26/2024

      Excellent doctor who show kindness and listens

      5 out of 5 stars
      Reviewed on 10/30/2024

      Excellent

      5 out of 5 stars
      Reviewed on 9/24/2024

      Knowledgeable, compassionate, attentive

      5 out of 5 stars
      Reviewed on 9/10/2024

      Great.Thank you.

      5 out of 5 stars
      Reviewed on 8/6/2024

      Excellent doctor. So fortunate to have her working with me on my health care journey.

      5 out of 5 stars
      Reviewed on 8/6/2024

      Very attuned to my situation and my questions

      5 out of 5 stars
      Reviewed on 7/16/2024

      Excellent Dr.

      5 out of 5 stars
      Reviewed on 7/9/2024

      Dr. Marrone is the best oncologist I am so thankful and grateful to her for all she has done. I love her from the bottom of my heart

      5 out of 5 stars
      Reviewed on 7/9/2024

      Excellent, takes time to explain all

      5 out of 5 stars
      Reviewed on 5/28/2024

      Awesome

      5 out of 5 stars
      Reviewed on 4/30/2024

      Listens and is concerned. Was late for appointment but gives time and concern for all patients. I feel was probably late because she was providing the time needed to patient before me.

      5 out of 5 stars
      Reviewed on 3/12/2024

      She is incredibly knowledgeable; open to my extensive questions, clarifies as needed, and is extremely empathetic regarding my concerns and situation.

      5 out of 5 stars
      Reviewed on 2/20/2024

      Very top of her profession. Outstanding, caring physician.